Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 15.35
-0.70 (-4.36%)
May 4, 2026, 5:29 PM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 401.14 million as of May 4, 2026. Its market cap has increased by 89.58% in one year.
Market Cap
401.14M
Enterprise Value
384.42M
Revenue
8.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.35
Market Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 401.14M, an increase of 309.47%. That is a compound annual growth rate of 13.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 401.14M | 13.82% |
| Dec 30, 2025 | 352.45M | 86.79% |
| Dec 30, 2024 | 188.69M | -41.07% |
| Dec 29, 2023 | 320.21M | 61.61% |
| Dec 30, 2022 | 198.15M | -36.85% |
| Dec 30, 2021 | 313.77M | 25.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 726.11M |
| FluoGuide | 668.69M |
| Oncopeptides AB | 515.45M |
| Ascelia Pharma AB | 400.61M |
| Intervacc AB | 389.21M |
| Sprint Bioscience AB | 328.15M |
| Mendus AB | 314.72M |
| Bio-Works Technologies AB | 314.03M |